NCT01218581View on ClinicalTrials.gov

Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis
Interventions
DRUG

received oral letrozole (2.5 mg/day)and goserelin subcutaneosly (3.6 mg/month)

Trial Locations (1)

35111

Mansoura University Hospitals, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT01218581 - Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis | Biotech Hunter | Biotech Hunter